Yes, verapamil is often combined with other antihypertensives such as ACE inhibitors or thiazide diuretics. However, the combination can increase the risk of low blood pressure, so the prescriber will monitor your readings and may adjust doses accordingly.
A marked slowing of the heart rate (bradycardia) can be a sign that the dose is too high or that an interaction is occurring. Contact your healthcare provider promptly; they may order an ECG and adjust the medication.
Yes, but keep the medication in its original packaging with a copy of the prescription. Be aware that some countries have strict import rules for prescription drugs; carrying a letter from your doctor can help at customs.
Grapefruit juice inhibits CYP3A4 enzymes in the gut, potentially raising verapamil levels and increasing side-effect risk. It is advisable to avoid large quantities of grapefruit while taking this medication.
Isoptin SR tablets are colour-coded and imprinted: 120 mg tablets are usually pink with “120 SR” marking, while 240 mg tablets are orange with “240 SR”. Verify the imprint against the packaging before use.
Routine monitoring of blood pressure, heart rate, and an ECG is essential. Liver and kidney function tests are recommended at baseline and periodically, especially if you have pre-existing organ impairment.
Abrupt discontinuation is generally not required, but you should discuss any changes with your prescriber. Stopping suddenly may cause rebound hypertension or arrhythmia recurrence.
Acetaminophen (paracetamol) is usually safe. Non-steroidal anti-inflammatory drugs (NSAIDs) can raise blood pressure and should be used cautiously; consult your pharmacist.
Some individuals experience dizziness or light-headedness, especially after the first few doses. If you feel any impairment, avoid driving until you know how the medication affects you.
The extended-release (SR) formulation provides a steadier blood concentration over 24 hours, allowing once-daily dosing. Immediate-release tablets require multiple daily doses and may cause more pronounced peaks and troughs in drug levels.
Isoptin SR is a prescription-only medication that contains the calcium-channel-blocking agent verapamil as its sole active ingredient. It is supplied as a pill in extended-release (SR, sustained-release) form, most commonly in 120 mg and 240 mg strengths. In the United Kingdom, Isoptin SR is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is indicated for the management of certain heart-related conditions, primarily hypertension, angina pectoris, and specific cardiac arrhythmias. The product is manufactured by Sanofi-Aspocomp (brand information based on publicly available labeling).
Ververapamil belongs to the calcium-channel blocker class, specifically targeting L-type calcium channels in cardiac and smooth-muscle cells.
The extended-release formulation allows a gradual rise in plasma concentration, providing a more stable therapeutic effect over 24 hours compared with immediate-release preparations. Onset of action typically occurs within 2-3 hours after ingestion, with peak plasma levels reached around 6-8 hours; the effect can last up to 24 hours.
Isoptin SR is authorised by the MHRA for the following prescribed indications:
These uses are supported by the British National Formulary (BNF) and the product’s summary of characteristics (SmPC). The medication is intended for adult patients; pediatric use is not approved.
Research outside the approved label has explored verapamil for several other conditions. When such evidence is cited, it is clearly identified as off-label and accompanied by appropriate caveats.
Disclaimer: Off-label use of Isoptin SR must be undertaken under the direct supervision of a qualified healthcare professional, with a thorough risk-benefit assessment for each individual patient.
If any of these serious symptoms occur, seek immediate medical attention.
Patients should provide a complete medication list-including over-the-counter products, herbal supplements, and vitamins-to their prescriber.
Standard adult dosing:
120 mg once daily for mild hypertension or as a start-dose for angina.
240 mg once daily for more severe hypertension, angina, or arrhythmia control. Dose may be titrated upward in 120 mg increments based on clinical response and tolerability, not exceeding 480 mg per day (two 240 mg tablets) unless specifically directed by a cardiologist.
Administration: Swallow the pill whole with a full glass of water. Do not crush, chew, or split the extended-release tablet, as this can lead to dose dumping and toxicity.
Timing: Take at the same time each day, preferably in the morning to minimise nocturnal hypotension, unless otherwise advised.
Missed dose: If a dose is missed and it is within 12 hours of the scheduled time, take it promptly. If more than 12 hours have elapsed, skip the missed dose and resume the regular schedule. Do not double-dose.
Overdose: Symptoms may include severe hypotension, bradycardia, cardiac arrest, and altered mental status. Seek emergency care immediately; treatment is supportive and may involve intravenous calcium gluconate, atropine, or temporary pacing.
Discontinuation: Abrupt cessation is not usually required, but dose reduction may be recommended in patients with chronic heart failure to avoid rebound hypertension. Tapering should be guided by the prescriber.
This article provides educational information about Isoptin SR and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
